92367-55-0

Basic information

• Product Name: 4-(4-hydroxybutyl)benzonitrile
• Synonyms: 4-(4-hydroxybutyl)benzonitrile
• CAS NO: 92367-55-0
• Molecular Weight: 175.23
• Mol File: 92367-55-0.mol

Chemical Properties

• CAS DataBase Reference: 4-(4-hydroxybutyl)benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-hydroxybutyl)benzonitrile(92367-55-0)
• EPA Substance Registry System: 4-(4-hydroxybutyl)benzonitrile(92367-55-0)

Safety Data

• Hazardous Substances Data: 92367-55-0(Hazardous Substances Data)

Upstream product

• 150465-56-8 4-(p-cyanophenyl)-3-buten-1-ol 
• 15451-33-9 4-(but-3-en-1-yl)benzonitrile 
• 623-03-0 4-Cyanochlorobenzene 
• 627-27-0 homoalylic alcohol 
• 623-00-7 4-bromobenzenecarbonitrile 

Downstream Products

• 1219041-08-3 4-(4-cyanophenyl)butyl methanesulfonate 
• 31419-48-4 4-(p-cyanophenyl)butanoic acid 

Relevant articles and documents

Radical Chain Reduction via Carbon Dioxide Radical Anion (CO2?-)

We developed an effective method for reductive radical formation that utilizes the radical anion of carbon dioxide (CO2?-) as a powerful single electron reductant. Through a polarity matched hydrogen atom transfer (HAT) between an electrophilic radical and a formate salt, CO2?- formation occurs as a key element in a new radical chain reaction. Here, radical chain initiation can be performed through photochemical or thermal means, and we illustrate the ability of this approach to accomplish reductive activation of a range of substrate classes. Specifically, we employed this strategy in the intermolecular hydroarylation of unactivated alkenes with (hetero)aryl chlorides/bromides, radical deamination of arylammonium salts, aliphatic ketyl radical formation, and sulfonamide cleavage. We show that the reactivity of CO2?- with electron-poor olefins results in either single electron reduction or alkene hydrocarboxylation, where substrate reduction potentials can be utilized to predict reaction outcome.

PHENETANOLAMINE DERIVATIVES

Compounds of formula (I) and salts, solvates, and physiologically functional derivatives thereof, useful for the prophylaxis or treatment of a clinical condition for which a selective β2-adrenoreceptor agonist is indicated, for example asthma or chronic o

Oxabispidine compounds useful in the treatment of cardiac arrhyythmias

There is provided compounds of formula I, wherein R1, R2, R3, R4, R41to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor

Peptide mimetics of the RGDF sequence in which Arg-Gly has been replaced with 5-(4-amidinophenyl)pentanoyl mimetic has led to a 1000-fold increase in inhibitory potency over the natural RGDF ligand. The guanidine residue of the arginine may be involved in